Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

293 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Preclinical study and phase II trial of adapting low-dose radiotherapy to immunotherapy in small cell lung cancer.
Wang H, Yao Z, Kang K, Zhou L, Xiu W, Sun J, Xie C, Yu M, Li Y, Zhang Y, Zheng Y, Lin G, Pan X, Wu Y, Luo R, Wang L, Tang M, Liao S, Zhu J, Zhou X, Zhang X, Xu Y, Liu Y, Peng F, Wang J, Xiang L, Yin L, Deng L, Huang M, Gong Y, Zou B, Wang H, Wu L, Yuan Z, Bi N, Fan M, Xu Y, Tong R, Yi L, Gan L, Xue J, Mo X, Chen C, Na F, Lu Y. Wang H, et al. Among authors: bi n. Med. 2024 Oct 11;5(10):1237-1254.e9. doi: 10.1016/j.medj.2024.06.002. Epub 2024 Jul 3. Med. 2024. PMID: 38964333 Free article. Clinical Trial.
Etoposide and cisplatin versus paclitaxel and carboplatin with concurrent thoracic radiotherapy in unresectable stage III non-small cell lung cancer: a multicenter randomized phase III trial.
Liang J, Bi N, Wu S, Chen M, Lv C, Zhao L, Shi A, Jiang W, Xu Y, Zhou Z, Wang W, Chen D, Hui Z, Lv J, Zhang H, Feng Q, Xiao Z, Wang X, Liu L, Zhang T, Du L, Chen W, Shyr Y, Yin W, Li J, He J, Wang L. Liang J, et al. Among authors: bi n. Ann Oncol. 2017 Apr 1;28(4):777-783. doi: 10.1093/annonc/mdx009. Ann Oncol. 2017. PMID: 28137739 Free article. Clinical Trial.
[Prognostic value of pretreatment neutrophil-to-lymphocyte ratio (NLR) in locally advanced non-small cell lung cancer patients treated with thoracic radiation].
Dong X, Zhou ZM, Bi N, Wang JB, Ran JT, Hui ZG, Liang J, Feng QF, Chen DF, Xiao ZF, Lyu JM, Wang XZ, Wang X, Zhang T, Deng L, Wang WQ, Wang LH. Dong X, et al. Among authors: bi n. Zhonghua Zhong Liu Za Zhi. 2018 Jun 23;40(6):446-451. doi: 10.3760/cma.j.issn.0253-3766.2018.06.009. Zhonghua Zhong Liu Za Zhi. 2018. PMID: 29936771 Chinese.
A phase I/II radiation dose escalation trial using simultaneous integrated boost technique with elective nodal irradiation and concurrent chemotherapy for unresectable esophageal Cancer.
Li C, Ni W, Wang X, Zhou Z, Deng W, Chang X, Chen D, Feng Q, Liang J, Wang X, Deng L, Wang W, Bi N, Zhang T, Xiao Z. Li C, et al. Among authors: bi n. Radiat Oncol. 2019 Mar 15;14(1):48. doi: 10.1186/s13014-019-1249-5. Radiat Oncol. 2019. PMID: 30876442 Free PMC article. Clinical Trial.
Comparison of efficacy and safety between simultaneous integrated boost intensity-modulated radiotherapy and conventional intensity-modulated radiotherapy in locally advanced non-small-cell lung cancer: a retrospective study.
Wang D, Bi N, Zhang T, Zhou Z, Xiao Z, Liang J, Chen D, Hui Z, Lv J, Wang X, Wang X, Deng L, Wang W, Wang J, Wang C, Lu X, Xu K, Wu L, Xue W, Feng Q, Wang L. Wang D, et al. Among authors: bi n. Radiat Oncol. 2019 Jun 13;14(1):106. doi: 10.1186/s13014-019-1259-3. Radiat Oncol. 2019. PMID: 31196118 Free PMC article.
[Study on safety of adjuvant radiotherapy concurrent with weekly chemotherapy for stage ⅡB-ⅣA esophageal carcinoma after radical resection].
Ni WJ, Yu SF, Yang JS, Zhang WC, Zhou ZM, Zhang HX, Chen DF, Feng QF, Lyu JM, Liang J, Wang XZ, Wang X, Deng L, Wang WQ, Zhang T, Bi N, Xiao ZF. Ni WJ, et al. Among authors: bi n. Zhonghua Zhong Liu Za Zhi. 2019 Jun 23;41(6):415-420. doi: 10.3760/cma.j.issn.0253-3766.2019.06.004. Zhonghua Zhong Liu Za Zhi. 2019. PMID: 31216826 Chinese.
293 results